ConductScience.org, home

Paper23964121

Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease.

Qi Y and 10 others. J Lipid Res, 2013. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease. Papers, record 23964121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23964121

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease.
PubMed
Journal
J Lipid Res
PubMed
Year
2013
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.43
iCite
Revised in PubMed
2021-10-21
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qi YYue
2Liu JJing
3Ma CChangsheng
4Wang WWei
5Liu XXiaohui
6Wang MMiao
7Lv QQiang
8Sun JJiayi
9Liu JJun
10Li YYan
11Zhao DDong

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anticholesteremic AgentsMajor topic
CholesterolMajor topic
Coronary DiseaseMajor topic
Heptanoic AcidsMajor topic
PyrrolesMajor topic
Absorption
Adult
Aged
Atorvastatin
Biomarkers
Cholesterol, LDL
Female
Humans
Male
Middle Aged
Risk

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119285158A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.Biochim Biophys Acta2009https://conductscience.org/library/papers/19285158PubMed
215805190Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15805190PubMed
315178557Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia.Arterioscler Thromb Vasc Biol2004https://conductscience.org/library/papers/15178557PubMed
419965915Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.J Clin Endocrinol Metab2010https://conductscience.org/library/papers/19965915PubMed
510865267Statins and risk of coronary heart disease.JAMA2000https://conductscience.org/library/papers/10865267PubMed
615173162Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis.J Biol Chem2004https://conductscience.org/library/papers/15173162PubMed
721855307Patterns of cholesterol metabolism: pathophysiological and therapeutic implications for dyslipidemias and the metabolic syndrome.Nutr Metab Cardiovasc Dis2011https://conductscience.org/library/papers/21855307PubMed
823235655Lipid lowering efficacy of atorvastatin.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/23235655PubMed
921215234[Real world use of statins for secondary prevention in patients with high risk coronary heart disease in China].Zhonghua Xin Xue Guan Bing Za Zhi2010https://conductscience.org/library/papers/21215234PubMed
1018376000Simvastatin with or without ezetimibe in familial hypercholesterolemia.N Engl J Med2008https://conductscience.org/library/papers/18376000PubMed
1116004682Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.Curr Med Res Opin2005https://conductscience.org/library/papers/16004682PubMed
1215249516Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.Circulation2004https://conductscience.org/library/papers/15249516PubMed
1321762916Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?Atherosclerosis2011https://conductscience.org/library/papers/21762916PubMed
142010695Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans.J Lipid Res1991https://conductscience.org/library/papers/2010695PubMed
151640845Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man.Metabolism1992https://conductscience.org/library/papers/1640845PubMed
1616216250Cholestanol: a serum marker to guide LDL cholesterol-lowering therapy.Atherosclerosis2006https://conductscience.org/library/papers/16216250PubMed
1712949359Changes in serum concentrations of noncholesterol sterols and lipoproteins in healthy subjects do not depend on the ratio of plant sterols to stanols in the diet.J Nutr2003https://conductscience.org/library/papers/12949359PubMed
1811530028Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins.Am J Med2001https://conductscience.org/library/papers/11530028PubMed
1919043140Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.J Lipid Res2009https://conductscience.org/library/papers/19043140PubMed
2019786566Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort.J Lipid Res2010https://conductscience.org/library/papers/19786566PubMed

See all 41 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
30101294Progress and perspectives in plant sterol and plant stanol research.Nutr Rev2018https://conductscience.org/library/papers/30101294PubMed
27648687Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatment.Pharmacogenomics2016https://conductscience.org/library/papers/27648687PubMed
27158237Black ginseng extract ameliorates hypercholesterolemia in rats.J Ginseng Res2016https://conductscience.org/library/papers/27158237PubMed
26148680Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study.BMC Res Notes2015https://conductscience.org/library/papers/26148680PubMed
25760954Lipid-lowering efficacy of atorvastatin.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/25760954PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23964121

GET https://conductscience.org/api/papers/v1/23964121/references?page=2